ZA200506610B - Nutraceuticals for the treatment, protection and restoration of connective tissues - Google Patents
Nutraceuticals for the treatment, protection and restoration of connective tissues Download PDFInfo
- Publication number
- ZA200506610B ZA200506610B ZA200506610A ZA200506610A ZA200506610B ZA 200506610 B ZA200506610 B ZA 200506610B ZA 200506610 A ZA200506610 A ZA 200506610A ZA 200506610 A ZA200506610 A ZA 200506610A ZA 200506610 B ZA200506610 B ZA 200506610B
- Authority
- ZA
- South Africa
- Prior art keywords
- sequence
- data
- frequency bands
- transmission
- frequency
- Prior art date
Links
- 210000002808 connective tissue Anatomy 0.000 title 1
- 239000002417 nutraceutical Substances 0.000 title 1
- 235000021436 nutraceutical agent Nutrition 0.000 title 1
- 230000005540 biological transmission Effects 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 36
- 230000014509 gene expression Effects 0.000 claims description 32
- 238000004891 communication Methods 0.000 claims description 28
- 238000012545 processing Methods 0.000 claims description 12
- 230000008569 process Effects 0.000 claims description 4
- 238000013507 mapping Methods 0.000 description 14
- 125000004122 cyclic group Chemical group 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000003068 static effect Effects 0.000 description 4
- 235000008694 Humulus lupulus Nutrition 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 238000003491 array Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Mobile Radio Communication Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS0112A AUPS011202A0 (en) | 2002-01-23 | 2002-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| AUPS1054A AUPS105402A0 (en) | 2002-03-12 | 2002-03-12 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200506610B true ZA200506610B (en) | 2006-07-26 |
Family
ID=27614006
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200506610A ZA200506610B (en) | 2002-01-23 | 2003-01-23 | Nutraceuticals for the treatment, protection and restoration of connective tissues |
| ZA200406621A ZA200406621B (en) | 2002-01-23 | 2004-08-19 | Nutraceuticals for the treatment, protection and restoration of connective tissues. |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200406621A ZA200406621B (en) | 2002-01-23 | 2004-08-19 | Nutraceuticals for the treatment, protection and restoration of connective tissues. |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7371820B2 (https=) |
| EP (1) | EP1476471A4 (https=) |
| JP (1) | JP2005519914A (https=) |
| AU (1) | AU2003201402B2 (https=) |
| CA (1) | CA2474269A1 (https=) |
| NZ (1) | NZ534760A (https=) |
| WO (1) | WO2003062279A1 (https=) |
| ZA (2) | ZA200506610B (https=) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7067123B2 (en) | 2003-04-29 | 2006-06-27 | Musculoskeletal Transplant Foundation | Glue for cartilage repair |
| AU2003903037A0 (en) * | 2003-06-17 | 2003-07-03 | Institute Of Nutraceutical Research | Connective tissue derived polypeptides |
| US20080200372A1 (en) * | 2004-01-16 | 2008-08-21 | Institute Of Nutraceutical Research Pty Ltd. | Glycosaminoglycan Peptides Derived From Connective Tissues And Use Thereof In The Prevention Of Arthritis And Other Degenerative Medical Conditions |
| US7837740B2 (en) | 2007-01-24 | 2010-11-23 | Musculoskeletal Transplant Foundation | Two piece cancellous construct for cartilage repair |
| US20090319045A1 (en) | 2004-10-12 | 2009-12-24 | Truncale Katherine G | Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles |
| AU2005202062B2 (en) * | 2005-01-14 | 2012-08-16 | Institute Of Nutraceutical Research Pty Ltd | Nutraceuticals for the treatment, protection, and restoration of connective tissues |
| JP4955944B2 (ja) * | 2005-06-30 | 2012-06-20 | 丸共バイオフーズ株式会社 | コンドロイチン硫酸カルシウム及びその製造方法 |
| US7943764B2 (en) * | 2005-10-27 | 2011-05-17 | Dimitry Alekseevich Savaschuk | Method for producing sulphated glycosaminoglycans from biological tissues |
| US20080279825A1 (en) * | 2007-05-10 | 2008-11-13 | Malinin Theodore I | Cartilage material |
| FR2918376B1 (fr) * | 2007-07-04 | 2011-10-28 | Mathieu Borge | Compositions liquides ou pateuses destinees a l'apport en elements essentiels a la synthese et a la constitution des proteoglycanes, notamment pour le traitement de la degradation du cartilage |
| JP5143621B2 (ja) * | 2008-05-08 | 2013-02-13 | 電気化学工業株式会社 | 哺乳動物由来の生体液試料中のヒアルロン酸の分子量分布の測定方法 |
| FR2938762B1 (fr) * | 2008-11-21 | 2011-02-04 | Oreal | Utilisation cosmetique de proteines de type dj-1 pour le traitement de la secheresse cutanee |
| WO2016111899A1 (en) | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating lung disorders |
| WO2016111900A1 (en) * | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating arthritis |
| JP2018515485A (ja) * | 2015-05-01 | 2018-06-14 | ザ プロクター アンド ギャンブル カンパニー | 皮膚の外観を改善する方法及びニコチンアミドリボシドを使用したそのための組成物 |
| WO2017004102A1 (en) | 2015-06-29 | 2017-01-05 | The Procter & Gamble Company | Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container |
| EP3236928B1 (en) | 2016-01-11 | 2020-12-09 | The Procter and Gamble Company | Method of treating a skin condition and compositions therefor |
| US10993969B2 (en) | 2016-02-05 | 2021-05-04 | Gary M. Petrucci | Methods and materials for treating nerve injuries and neurological disorders |
| US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
| CN110785161B (zh) | 2017-06-23 | 2023-06-20 | 宝洁公司 | 用于改善皮肤外观的组合物和方法 |
| US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
| CN112437657A (zh) | 2018-07-03 | 2021-03-02 | 宝洁公司 | 处理皮肤状况的方法 |
| CN111235202B (zh) * | 2018-11-29 | 2022-03-08 | 中国中医科学院医学实验中心 | 一种鹿骨蛋白质提取物及其制备方法与应用 |
| JP7590462B2 (ja) | 2020-06-01 | 2024-11-26 | ザ プロクター アンド ギャンブル カンパニー | ビタミンｂ３化合物の皮膚への浸透を改善する方法 |
| US10959933B1 (en) | 2020-06-01 | 2021-03-30 | The Procter & Gamble Company | Low pH skin care composition and methods of using the same |
| CN113603762B (zh) * | 2021-08-20 | 2023-06-27 | 吉林农业大学 | 一种花马杂交鹿鹿角盘活性肽及其制备方法和应用 |
| ES2956802B2 (es) * | 2022-05-20 | 2025-10-02 | Bioiberica S A U | Hidrogeles para su uso en ingenieria de tejidos de la piel |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE857389A (fr) * | 1977-08-02 | 1977-12-01 | Marbex Finance Ltd | Procede de preparation de chondroitines-sulfates de metaux alcalins et alcalino-terreux d'un poids moleculaire de 3000 a 6000 |
| CA1302880C (en) | 1986-07-25 | 1992-06-09 | Peter Koepff | Agents for the treatment of arthroses |
| US5399347A (en) | 1987-06-24 | 1995-03-21 | Autoimmune, Inc. | Method of treating rheumatoid arthritis with type II collagen |
| US6136793A (en) * | 1992-02-20 | 2000-10-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| JP3248170B2 (ja) * | 1992-12-11 | 2002-01-21 | マルハ株式会社 | コンドロイチン硫酸蛋白複合体含有食品 |
| US6492349B1 (en) * | 1993-03-31 | 2002-12-10 | Nutramax Laboratories, Inc. | Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue |
| US5364845C1 (en) | 1993-03-31 | 2002-09-10 | Nutramax Lab Inc | Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue |
| AU7205894A (en) * | 1993-06-08 | 1995-01-03 | Neogenix, Inc. | Purified natural and synthetic compounds for the treatment of osteoarthritis |
| EP0873128B1 (en) * | 1996-01-11 | 2004-11-17 | Jagotec Ag | Oral administration of effective amounts of forms of hyaluronic acid |
| TW472045B (en) * | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| WO1999001143A1 (en) * | 1997-07-03 | 1999-01-14 | Orquest, Inc. | Cross-linked polysaccharide drug carrier |
| US6025327A (en) | 1997-08-08 | 2000-02-15 | Biocell Technology, Llc | Hydrolyzed collagen type II and use thereof |
| US5922692A (en) * | 1998-03-11 | 1999-07-13 | Marino; Richard P. | Concentration of glycosaminoglycans and precursors thereto in food products |
| US6162787A (en) * | 1999-04-02 | 2000-12-19 | Immudyne, Inc. | Methods for treating arthritis using collagen type II, glucosamine chondroitin sulfate, and compositions |
| JP3271008B2 (ja) * | 1999-11-18 | 2002-04-02 | 独立行政法人産業技術総合研究所 | コンドロイチン硫酸類の製造方法 |
| DE10008896A1 (de) * | 2000-02-25 | 2001-08-30 | Beiersdorf Ag | Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Benzotriazolderivaten und Alkylnaphthalaten |
| HUP0302396A2 (hu) * | 2000-05-05 | 2003-10-28 | Gtc Biotherapeutics, Inc. | Transzgénikus úton előállított dekorin |
| US6924273B2 (en) * | 2000-10-03 | 2005-08-02 | Scott W. Pierce | Chondroprotective/restorative compositions and methods of use thereof |
-
2003
- 2003-01-23 CA CA002474269A patent/CA2474269A1/en not_active Abandoned
- 2003-01-23 NZ NZ534760A patent/NZ534760A/xx not_active IP Right Cessation
- 2003-01-23 WO PCT/AU2003/000061 patent/WO2003062279A1/en not_active Ceased
- 2003-01-23 ZA ZA200506610A patent/ZA200506610B/en unknown
- 2003-01-23 AU AU2003201402A patent/AU2003201402B2/en not_active Ceased
- 2003-01-23 JP JP2003562156A patent/JP2005519914A/ja active Pending
- 2003-01-23 EP EP03700092A patent/EP1476471A4/en not_active Withdrawn
-
2004
- 2004-07-22 US US10/896,546 patent/US7371820B2/en not_active Expired - Fee Related
- 2004-08-19 ZA ZA200406621A patent/ZA200406621B/en unknown
-
2005
- 2005-05-16 US US11/130,470 patent/US7211648B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003062279A1 (en) | 2003-07-31 |
| US7371820B2 (en) | 2008-05-13 |
| CA2474269A1 (en) | 2003-07-31 |
| AU2003201402B2 (en) | 2004-12-09 |
| ZA200406621B (en) | 2005-09-28 |
| JP2005519914A (ja) | 2005-07-07 |
| US20050020500A1 (en) | 2005-01-27 |
| EP1476471A4 (en) | 2005-03-16 |
| US7211648B2 (en) | 2007-05-01 |
| US20060040851A1 (en) | 2006-02-23 |
| EP1476471A1 (en) | 2004-11-17 |
| NZ534760A (en) | 2006-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2004214058B2 (en) | Frequency hop sequences for multi-band communication systems | |
| ZA200506610B (en) | Nutraceuticals for the treatment, protection and restoration of connective tissues | |
| US8879378B2 (en) | Orthonormal time-frequency shifting and spectral shaping communications method | |
| EP3912340B1 (en) | Sub-band and multi-band coded ofdm for high-resolution radar | |
| RU2404529C2 (ru) | Способ и устройство для мультиплексирования пилот-сигнала в системе беспроводной связи | |
| EP3934189B1 (en) | Random access cyclic prefix dimensioning in wireless networks | |
| EP3211846B1 (en) | Multiuser communication methods and devices for code division multiple access | |
| KR102065345B1 (ko) | 다중 사용자 코드 분할 다중 접속 통신 방법 및 상응한 송신기, 수신기 | |
| US20070177631A1 (en) | Multiplexing scheme in a communication system | |
| EP1755299A2 (en) | Transmitting/receiving apparatus and method for cell search in a broadband wireless communication system using multiple carriers | |
| CN111684731B (zh) | 通信方法、通信设备和网络设备 | |
| JP2010516121A (ja) | 無線通信システムにおけるパイロット通信 | |
| JP2009505503A (ja) | シングルキャリアおよびマルチキャリア周波数分割多元接続方式におけるチャネルおよび干渉推定 | |
| CN102132519A (zh) | 频域pn序列 | |
| EP3895498A1 (en) | Client device and network access node for transmitting and receiving a random access preamble | |
| EP2624479A1 (en) | Preamble sequence detection apparatus | |
| CN112136300A (zh) | 通信方法、通信设备和网络设备 | |
| HK1087259A (en) | Frequency hop sequences for multi-band communication systems |